Frankfurt - Delayed Quote EUR

Enlivex Therapeutics Ltd. (1BT.F)

Compare
1.0500
0.0000
(0.00%)
As of 8:06:30 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
36,831.0000
67,642.0000
95,146.0000
40,358.0000
Total Liabilities Net Minority Interest
6,747.0000
10,801.0000
10,107.0000
4,871.0000
Total Equity Gross Minority Interest
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Total Capitalization
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Common Stock Equity
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Capital Lease Obligations
1,032.0000
4,847.0000
6,006.0000
203.0000
Net Tangible Assets
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Working Capital
27,703.0000
45,723.0000
81,724.0000
33,749.0000
Invested Capital
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Tangible Book Value
30,084.0000
56,841.0000
85,039.0000
35,487.0000
Total Debt
1,032.0000
4,847.0000
6,006.0000
203.0000
Share Issued
18,598.5550
18,421.8520
18,331.5070
14,587.9340
Ordinary Shares Number
18,598.5550
18,421.8520
18,331.5070
14,587.9340
12/31/2020 - 7/23/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers